Developing countries have widely varying levels of scientific and technological capacity. Some countries, particularly large ones such as India, China, and Brazil, have strong research and development capabilities in the public sector and, to a lesser extent in the private sector.
However, if countries are to be genuinely in a position to meet the health needs of their populations, even if relying largely on products developed elsewhere, they need to have, at a minimum, a range of expertise across medical disciplines to use such products effectively in their own health systems. Beyond that, many countries wish to develop a capacity for innovation which will be responsive to their own disease and risk burdens.
Manufacture of antiretrovirals in developing countries and challenges for the future | Report by the (WHO) Secretariat | EB114/15 World Health Organization | 29 April 2004
Human Development Report | Chapter 4-Unleashing human creativity: national strategies | UNDP, (2001) pp.79-93
Human Development Report | Chapter 5- Global initiatives to create technologies for human development | UNDP, (2001) pp.95-130
- Biotechnology opportunities for developing countries: special supplement to the December 2004 issue of Nature Biotechnology, presents case studies of progress in health biotechnology in seven countries in the developing world.